• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Depression in Parkinson's disease: a quantitative and qualitative analysis.帕金森病中的抑郁:定量与定性分析
J Neurol Neurosurg Psychiatry. 1986 Apr;49(4):381-9. doi: 10.1136/jnnp.49.4.381.
2
Application of depression rating scales in patients with Parkinson's disease with and without co-Occurring anxiety.抑郁评定量表在伴或不伴共病焦虑的帕金森病患者中的应用。
J Parkinsons Dis. 2013;3(4):603-8. doi: 10.3233/JPD-130264.
3
Effect of reboxetine on depression in Parkinson's disease patients.瑞波西汀对帕金森病患者抑郁的影响。
J Clin Psychiatry. 2002 Apr;63(4):300-4. doi: 10.4088/jcp.v63n0405.
4
Anxiety, depression, and quality of life in Parkinson's disease.帕金森病患者的焦虑、抑郁和生活质量。
J Neuropsychiatry Clin Neurosci. 2009 Fall;21(4):413-9. doi: 10.1176/jnp.2009.21.4.413.
5
Apathy in elderly nondemented patients with Parkinson's disease: clinical determinants and relationship to quality of life.老年非痴呆型帕金森病患者的淡漠:临床决定因素及其与生活质量的关系。
J Geriatr Psychiatry Neurol. 2013 Dec;26(4):237-43. doi: 10.1177/0891988713500587. Epub 2013 Aug 22.
6
[Role of demotivation and affective disorders in apathy in patients with Parkinson's disease without dementia and depression].[动机缺乏和情感障碍在无痴呆及抑郁的帕金森病患者冷漠症状中的作用]
Geriatr Psychol Neuropsychiatr Vieil. 2013 Jun;11(2):197-207. doi: 10.1684/pnv.2013.0404.
7
Parkinson's disease and anxiety: comorbidity with depression.帕金森病与焦虑症:与抑郁症的共病情况。
Biol Psychiatry. 1993 Oct 1;34(7):465-70. doi: 10.1016/0006-3223(93)90237-8.
8
Depression and disability in Parkinson's disease: a follow-up of 132 cases.帕金森病中的抑郁与残疾:132例随访研究
Psychol Med. 1988 Feb;18(1):49-55. doi: 10.1017/s0033291700001872.
9
Clinical phenotype of drug-naïve Parkinson's disease based on nonmotor symptoms.基于非运动症状的初发帕金森病临床表型
Arch Gerontol Geriatr. 2015 Nov-Dec;61(3):517-22. doi: 10.1016/j.archger.2015.07.001. Epub 2015 Jul 6.
10
Psychopathological symptoms of depression in Parkinson's disease compared to major depression.帕金森病中抑郁的精神病理症状与重度抑郁症的比较。
Psychopathology. 2003 Sep-Oct;36(5):221-5. doi: 10.1159/000073446.

引用本文的文献

1
An Explainable Approach to Parkinson's Diagnosis Using the Contrastive Explanation Method-CEM.一种使用对比解释方法(CEM)进行帕金森病诊断的可解释方法。
Diagnostics (Basel). 2025 Aug 18;15(16):2069. doi: 10.3390/diagnostics15162069.
2
Psychiatric Disorders and Cognitive Fluctuations in Parkinson's Disease: Changing Approaches in the First Decades of the 21st Century.帕金森病中的精神障碍与认知波动:21世纪头十年不断变化的研究方法
Brain Sci. 2024 Dec 8;14(12):1233. doi: 10.3390/brainsci14121233.
3
Depressive symptoms in Parkinson's disease are insufficiently but more often treated than in other chronic conditions.帕金森病中的抑郁症状治疗不足,但与其他慢性疾病相比,其接受治疗的情况更为常见。
NPJ Parkinsons Dis. 2023 Jul 14;9(1):113. doi: 10.1038/s41531-023-00551-8.
4
Early identification of subjective cognitive functional decline among patients with Parkinson's disease: a longitudinal pilot study.帕金森病患者主观认知功能下降的早期识别:一项纵向初步研究。
Sci Rep. 2022 Dec 23;12(1):22242. doi: 10.1038/s41598-022-26280-1.
5
Brain microstructural alterations of depression in Parkinson's disease: A systematic review of diffusion tensor imaging studies.帕金森病患者抑郁的脑微观结构改变:弥散张量成像研究的系统评价。
Hum Brain Mapp. 2022 Dec 15;43(18):5658-5680. doi: 10.1002/hbm.26015. Epub 2022 Jul 20.
6
Antidepressant-Like Properties of Intrastriatal Botulinum Neurotoxin-A Injection in a Unilateral 6-OHDA Rat Model of Parkinson's Disease.纹状体内注射肉毒杆菌神经毒素 A 对单侧 6-羟多巴胺帕金森病大鼠模型的抗抑郁样作用。
Toxins (Basel). 2021 Jul 20;13(7):505. doi: 10.3390/toxins13070505.
7
Management of psychiatric disorders in Parkinson's disease : Neurotherapeutics - Movement Disorders Therapeutics.帕金森病相关精神障碍的治疗:神经治疗学-运动障碍治疗学。
Neurotherapeutics. 2020 Oct;17(4):1511-1524. doi: 10.1007/s13311-020-00875-w.
8
Lewy Body Degenerations as Neuropsychiatric Disorders.路易体变性作为神经精神障碍。
Psychiatr Clin North Am. 2020 Jun;43(2):361-381. doi: 10.1016/j.psc.2020.02.003. Epub 2020 Apr 8.
9
Parkinson's Disease Multimodal Complex Treatment improves motor symptoms, depression and quality of life.帕金森病多模态综合治疗改善运动症状、抑郁和生活质量。
J Neurol. 2020 Apr;267(4):954-965. doi: 10.1007/s00415-019-09657-7. Epub 2019 Dec 3.
10
Cognitive Functional Abilities in Parkinson's Disease: Agreement Between Patients and Informants.帕金森病的认知功能能力:患者与 informant 之间的一致性。 (注:这里“informant”在医学语境中常译为“知情者”,比如患者家属等能提供相关信息的人 )
Mov Disord Clin Pract. 2019 May 17;6(6):440-445. doi: 10.1002/mdc3.12781. eCollection 2019 Jul.

本文引用的文献

1
A rating scale for depression.一种抑郁症评定量表。
J Neurol Neurosurg Psychiatry. 1960 Feb;23(1):56-62. doi: 10.1136/jnnp.23.1.56.
2
An inventory for measuring depression.一份用于测量抑郁的量表。
Arch Gen Psychiatry. 1961 Jun;4:561-71. doi: 10.1001/archpsyc.1961.01710120031004.
3
Depression, intellectual impairment, and Parkinson disease.抑郁症、智力障碍与帕金森病。
Neurology. 1981 Jun;31(6):645-50. doi: 10.1212/wnl.31.6.645.
4
Symptoms of depression in Parkinson's disease.帕金森病中的抑郁症状。
Pharmacopsychiatria. 1982 Nov;15(6):192-6. doi: 10.1055/s-2007-1019537.
5
Anti-depressive treatment in Parkinson's disease. A controlled trial of the effect of nortriptyline in patients with Parkinson's disease treated with L-DOPA.帕金森病的抗抑郁治疗。去甲替林对接受左旋多巴治疗的帕金森病患者疗效的对照试验。
Acta Neurol Scand. 1980 Oct;62(4):210-9. doi: 10.1111/j.1600-0404.1980.tb03028.x.
6
Coping with chronic illness: a study of illness controllability and the influence of coping strategies on psychological adjustment.应对慢性病:疾病可控性及应对策略对心理调适影响的研究
J Consult Clin Psychol. 1984 Jun;52(3):343-53. doi: 10.1037//0022-006x.52.3.343.
7
Depression: relationship to somatization and chronic medical illness.抑郁症:与躯体化及慢性疾病的关系。
J Clin Psychiatry. 1984 Mar;45(3 Pt 2):4-12.
8
Diagnosing depression in the hospitalized patient with chronic medical illness.诊断患有慢性疾病的住院患者的抑郁症。
J Clin Psychiatry. 1984 Mar;45(3 Pt 2):13-7.
9
Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease.帕金森病中皮质多巴胺、去甲肾上腺素、5-羟色胺及其代谢产物的减少。
Brain Res. 1983 Sep 26;275(2):321-8. doi: 10.1016/0006-8993(83)90993-9.
10
Parkinsonism: onset, progression and mortality.帕金森症:发病、进展与死亡率
Neurology. 1967 May;17(5):427-42. doi: 10.1212/wnl.17.5.427.

帕金森病中的抑郁:定量与定性分析

Depression in Parkinson's disease: a quantitative and qualitative analysis.

作者信息

Gotham A M, Brown R G, Marsden C D

出版信息

J Neurol Neurosurg Psychiatry. 1986 Apr;49(4):381-9. doi: 10.1136/jnnp.49.4.381.

DOI:10.1136/jnnp.49.4.381
PMID:3701347
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1028762/
Abstract

Depression is a common feature of Parkinson's disease, a fact of both clinical and theoretical significance. Assessment of depression in Parkinson's disease is complicated by overlapping symptomatology in the two conditions, making global assessments based on observer or self-ratings of doubtful validity. The present study aimed to provide both a quantitative and qualitative description of the nature of the depressive changes found in Parkinson's disease as compared with normal elderly subjects and arthritis patients. As with previous studies, the patients with Parkinson's disease scored significantly higher than normal controls on various self-ratings of depression and anxiety but, in this study, did not differ from those with arthritis. Qualitatively, both the Parkinson's disease and the arthritis groups had depression characterised by pessimism and hopelessness, decreased motivation and drive, and increased concern with health. In contrast, the negative affective feelings of guilt, self-blame and worthlessness were absent in both patient groups. This pattern of depression was significantly associated with severity of illness and functional disability. However, these factors account for only a modest proportion of the variability in test scores. Probable unexplored factors are individual differences in coping style and availability of support.

摘要

抑郁症是帕金森病的一个常见特征,这一事实具有临床和理论双重意义。帕金森病患者的抑郁症评估因两种病症症状重叠而变得复杂,这使得基于观察者或自我评分的整体评估的有效性存疑。本研究旨在对帕金森病患者与正常老年受试者及关节炎患者相比所发现的抑郁变化的性质进行定量和定性描述。与先前的研究一样,帕金森病患者在各种抑郁和焦虑自我评分上的得分显著高于正常对照组,但在本研究中,他们与关节炎患者并无差异。从定性角度来看,帕金森病组和关节炎组的抑郁症都表现为悲观和绝望、动力和干劲下降以及对健康的担忧增加。相比之下,两个患者组均不存在内疚、自责和无价值感等负面情感。这种抑郁模式与疾病严重程度和功能残疾显著相关。然而,这些因素仅占测试分数变异性的一小部分。可能未被探究的因素是应对方式的个体差异和支持的可获得性。